Bladder Cancer - Results from #580

REVIEW UroToday

Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-Year Outcomes from a Randomised Controlled Trial. February 13, 2024

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection. February 13, 2024

The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. February 12, 2024

Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance. February 12, 2024

Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis. February 9, 2024

Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study. February 9, 2024

Prognostic Significance of Lymph Node Density in Pathological Node Positive Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant Chemotherapy Cohorts. February 8, 2024

Successful bladder-sparing partial cystectomy for muscle-invasive domal urothelial carcinoma with sarcomatoid differentiation: a case report. February 8, 2024

Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities? February 7, 2024

Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer. February 7, 2024

HPV and Squamous Cell Carcinoma of the Bladder - Expert Commentary February 6, 2024

Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer. February 6, 2024

Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database. February 6, 2024

Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer. February 5, 2024

Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials. February 5, 2024

Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases. February 2, 2024

Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample. February 2, 2024

New Photocure White Paper addressing Inequality in Bladder Cancer Care and the importance of Real World Evidence February 1, 2024

Perioperative and Complication-Related Outcomes for Robotic-Assisted versus Open Radical Cystectomy: A Comparative NSQIP Analysis. February 1, 2024

Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer. February 1, 2024

Page 30 of 517